SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Paimon SpaceX SPV Token (SPCX) offers investors exclusive access to SpaceX's growth potential through a British Virgin Islands Special Purpose Vehicle structure. Each token represents fractional ownership in the underlying SPV that invests in venture capital funds with SpaceX exposure. SPCX provides a unique opportunity to participate in the space industry's leading innovator. The token structure enables global qualified investors to access this premium late-stage venture equity that would typically be unavailable to most. SPCX is deployed on BNB Chain with plans for multi-chain expansion.

Paimon SpaceX SPV Token

Market sentiment is highly active around the reported upcoming SpaceX IPO, with community members closely tracking the potential June listing on the Nasdaq under the ticker symbol SPCX. While some investors are excited about the prospect of this major valuation event, others are debating whether the hype surrounding the ticker and related proxy stocks reflects genuine liquidity or speculative front-running.

Tidal Trust II - Defiance Daily Target 2X Long IONQ ETF

Defiance Daily Target 2X Long IONQ ETF

Investors are actively debating the high-risk, high-reward potential of this leveraged ETF, with many traders employing aggressive dollar-cost averaging and rotation strategies to capitalize on volatility tied to its underlying quantum computing exposure. The community sentiment remains polarized between long-term confidence in quantum sector growth and concerns over the decay inherent in leveraged products.

Kura Sushi USA, Inc. engages in the operation of technology enabled Japanese restaurants. It offers a distinctive dining experience by serving authentic Japanese cuisine through engaging revolving sushi service models. The company was founded by Hajime Uba in 2008 and is headquartered in Irvine, CA.

Kura Sushi USA Inc - Ordinary Shares - Class A

Kura Sushi USA is drawing significant investor attention as community members debate whether recent price volatility presents a buying opportunity or a signal of fundamental weakness. Discussions are heavily focused on the stock's high short interest and aggressive expansion plans, with market participants closely monitoring the upcoming earnings reports to gauge if the company's unit growth can maintain its momentum.

Tema ETF Trust - Tema Space Innovators ETF

The newly launched Tema Space Innovators ETF ($NASA) is generating significant community buzz as a rare, pure-play vehicle offering retail investors structured exposure to SpaceX via a 10% holding, ahead of the company's highly anticipated IPO. Investors are actively discussing the fund's potential to capture the broader space infrastructure cycle while debating whether its unique pre-IPO allocation will drive the same aggressive momentum seen in similar niche thematic plays.

DocuSign, Inc. engages in the provision of cloud-based electronic signature solutions, which helps companies and individuals securely collect information, automate data workflows, and sign anything. The firm automates manual and paper-based processes allowing users to manage all aspects of documented business transactions including identity management, authentication, digital signature, forms and data collection, collaboration, workflow automation, and storage. Its products include eSignature, CLM, Gen for Salesforce, Document Generation, Standards-Based Signatures, Notary and Web Forms. The company was founded by Thomas H. Gonser and Court Lorenzini in 2003 and is headquartered in San Francisco, CA.

DocuSign Inc

DocuSign is trending as investors weigh strong earnings and share repurchases against cautious forward guidance, sparking debate over whether the firm's AI-driven Intelligent Agreement Management (IAM) platform can maintain a competitive moat. Community sentiment remains sharply divided between bulls betting on a valuation recovery fueled by solid fundamentals and bears concerned that AI disruption will commoditize the company's core signature services.

GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.

GRAIL Inc.

GRAIL shares have experienced a significant sell-off after the company's multi-cancer early detection test failed to meet its primary clinical endpoint in a large-scale NHS study. While the community is debating whether this represents a total failure or an overreaction given the company's solid cash position and potential for early-stage cancer detection, investors remain highly cautious about the long-term regulatory path and the company's significant cash burn.

Collaborative Investment Series Trust - The SPAC and New Issue ETF

The SPCX ticker is attracting significant attention as investors speculate on potential connections to a highly anticipated SpaceX IPO, leading to intense community discussion and confusion about its actual purpose as a SPAC ETF. While some market participants are trading based on the hopes of a direct SpaceX link, others are focusing on the ETF's broader portfolio management and its strategic moves within the SPAC market.

Keysight Technologies, Inc. engages in the provision of electronic design and test solutions that are used in the design, development, manufacture, installation, deployment, validation, optimization, and secure operation of electronics systems to communications, networking, and electronics industries. It operates through the Communications Solutions Group (CSG) and Electronic Industrial Solutions Group (EISG) segments. The CSG segment serves customers spanning the global commercial communications and aerospace, defense, and government end markets. The EISG segment offers test and measurement solutions across electronic industrial end markets, focusing on applications in the automotive, and energy industry and measurement solutions for semiconductor design and manufacturing, consumer electronics, education, and general electronics manufacturing. The company was founded by William R. Hewlett and David Packard in 1937 and is headquartered in Santa Rosa, CA.

Keysight Technologies Inc

Keysight Technologies is currently trending as a significant play in the AI infrastructure space, with investors highlighting its critical role in high-frequency testing, data center connectivity, and the emerging 6G landscape. The community is actively debating the stock's momentum ahead of its upcoming earnings report, weighing strong institutional interest and recent price target hikes against concerns about potential overextension.

Elbit Systems Ltd. engages in the defense and homeland security sector. It develops and supplies airborne, land and naval systems and products for defense, homeland security, and commercial applications. The firm also provides training and support services. The company was founded in 1996 and is headquartered in Haifa, Israel.

Elbit Systems Ltd.

Elbit Systems is capturing significant market attention as investors weigh its robust global order backlog against ongoing geopolitical demand for its specialized defense and surveillance technologies. While some market participants debate the stock's valuation, community discussion is heavily focused on potential new partnerships and the company's critical role in the expanding defense technology sector.

Onto Innovation, Inc. engages in the business of designing, development, manufacturing, and support of high-performance control metrology, defect inspection, lithography, and data analysis systems used by microelectronics device manufacturers. It is also involved in providing process and yield management solutions used in bare silicon wafer production and wafer processing facilities. The company was founded in 1940 and is headquartered in Wilmington, MA.

Onto Innovation Inc.

Onto Innovation is gaining momentum as investors focus on its critical role in the AI infrastructure supply chain, particularly for advanced chip inspection, metrology, and high-bandwidth memory (HBM) packaging. Community members are actively highlighting the company's vital position in supporting the yield and reliability needs of next-generation logic and memory devices as AI-driven capital expenditures ramp up.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

LivaNova (LIVN) Upgraded to Buy: Here's What You Should Know

LivaNova (LIVN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

LivaNova Q1 Earnings Call Highlights

LivaNova (NASDAQ:LIVN) reported first-quarter 2026 results that management said reflected "durable performance" across its cardiopulmonary and epilepsy businesses, while also highlighting recent regulatory and clinical milestones that it believes position the company for entry into the obstructive s...

LivaNova (LIVN) Q2 2025 Earnings Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

LivaNova (LIVN) Q1 Earnings and Revenues Surpass Estimates

LivaNova (LIVN) delivered earnings and revenue surprises of +15.29% and +3.60%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

LivaNova (NASDAQ:LIVN) Issues FY 2026 Earnings Guidance

LivaNova (NASDAQ:LIVN) updated its FY 2026 earnings guidance. The company provided EPS guidance of 4.200-4.300 for the period, compared to the consensus estimate of 4.100. The company also issued...

LivaNova Reports First-Quarter 2026 Results; Raises Full-Year 2026 Revenue and Adjusted Diluted EPS Guidance

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today reported results for the first quarter ended March 31, 2026 and raised full-year 2026 guidance. Financial Summary and...

LivaNova (LIVN) Projected to Post Earnings on Wednesday

LivaNova (NASDAQ:LIVN) will be releasing its Q1 2026 earnings before the market opens on Wednesday, May 6. (View Earnings Report at...

Peregrine Capital Management LLC Invests $3.83 Million in LivaNova PLC $LIVN

Peregrine Capital Management LLC acquired a new position in LivaNova PLC (NASDAQ:LIVN - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange...

LivaNova (NASDAQ:LIVN) Shares Cross Below 50 Day Moving Average   - Here's Why

LivaNova (NASDAQ:LIVN) Stock Passes Below 50-Day Moving Average - Here's What Happened...

Annals of Internal Medicine Publishes 12-Month Results from LivaNovas OSPREY Clinical Study for Obstructive Sleep Apnea

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that the journal Annals of Internal Medicine has published an article chronicling the full 12-month data set...

LivaNova Plc is a global medical technology company, which engages in the development and delivery of therapeutic solutions for the benefit of patients, healthcare professionals, and healthcare systems. It operates through the following segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support (ACS). The Cardiopulmonary segment is involved in the design, development, manufacture, marketing and selling of cardiopulmonary products. The Neuromodulation segment is associated in the design, development, manufacture, marketing and selling of devices that deliver neuromodulation therapy for treating DRE and DTD. The ACS segment deals with the design, development, manufacture, marketing and selling of temporary life support products. The company was founded in 1987 and is headquartered in London, the United Kingdom.

LIVN
LivaNova PLC

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Latest LIVN News

LIVNLivaNova PLC